PMC:7228307 / 11442-11662 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"216","span":{"begin":33,"end":37},"obj":"Gene"},{"id":"217","span":{"begin":182,"end":186},"obj":"Gene"},{"id":"218","span":{"begin":203,"end":211},"obj":"Gene"},{"id":"224","span":{"begin":95,"end":101},"obj":"Species"},{"id":"226","span":{"begin":13,"end":20},"obj":"Gene"}],"attributes":[{"id":"A216","pred":"tao:has_database_id","subj":"216","obj":"Gene:3502"},{"id":"A217","pred":"tao:has_database_id","subj":"217","obj":"Gene:3502"},{"id":"A218","pred":"tao:has_database_id","subj":"218","obj":"Gene:2214"},{"id":"A224","pred":"tao:has_database_id","subj":"224","obj":"Tax:9606"},{"id":"A226","pred":"tao:has_database_id","subj":"226","obj":"Gene:2212"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"; mast cells\nFcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes\nFcγRIIc a Low IgG1, IgG3, IgG4 NK cells\nFcγRIIIa Low Ig"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T97","span":{"begin":2,"end":12},"obj":"Body_part"},{"id":"T98","span":{"begin":7,"end":12},"obj":"Body_part"},{"id":"T99","span":{"begin":108,"end":118},"obj":"Body_part"},{"id":"T100","span":{"begin":123,"end":132},"obj":"Body_part"},{"id":"T101","span":{"begin":146,"end":159},"obj":"Body_part"},{"id":"T102","span":{"begin":194,"end":202},"obj":"Body_part"},{"id":"T103","span":{"begin":197,"end":202},"obj":"Body_part"}],"attributes":[{"id":"A97","pred":"fma_id","subj":"T97","obj":"http://purl.org/sig/ont/fma/fma66784"},{"id":"A98","pred":"fma_id","subj":"T98","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A99","pred":"fma_id","subj":"T99","obj":"http://purl.org/sig/ont/fma/fma62852"},{"id":"A100","pred":"fma_id","subj":"T100","obj":"http://purl.org/sig/ont/fma/fma62851"},{"id":"A101","pred":"fma_id","subj":"T101","obj":"http://purl.org/sig/ont/fma/fma62869"},{"id":"A102","pred":"fma_id","subj":"T102","obj":"http://purl.org/sig/ont/fma/fma63147"},{"id":"A103","pred":"fma_id","subj":"T103","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"; mast cells\nFcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes\nFcγRIIc a Low IgG1, IgG3, IgG4 NK cells\nFcγRIIIa Low Ig"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T198","span":{"begin":7,"end":12},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T199","span":{"begin":13,"end":15},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T200","span":{"begin":71,"end":73},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T201","span":{"begin":146,"end":147},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T202","span":{"begin":160,"end":162},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T203","span":{"begin":168,"end":169},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T204","span":{"begin":194,"end":202},"obj":"http://purl.obolibrary.org/obo/CL_0000623"},{"id":"T205","span":{"begin":203,"end":205},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"; mast cells\nFcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes\nFcγRIIc a Low IgG1, IgG3, IgG4 NK cells\nFcγRIIIa Low Ig"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T72","span":{"begin":7,"end":12},"obj":"http://purl.obolibrary.org/obo/CL_0000000"},{"id":"T73","span":{"begin":108,"end":118},"obj":"http://purl.obolibrary.org/obo/CL_0000738"},{"id":"T74","span":{"begin":197,"end":202},"obj":"http://purl.obolibrary.org/obo/CL_0000000"}],"text":"; mast cells\nFcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes\nFcγRIIc a Low IgG1, IgG3, IgG4 NK cells\nFcγRIIIa Low Ig"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"216","span":{"begin":33,"end":37},"obj":"Gene"},{"id":"217","span":{"begin":182,"end":186},"obj":"Gene"},{"id":"218","span":{"begin":203,"end":211},"obj":"Gene"},{"id":"224","span":{"begin":95,"end":101},"obj":"Species"},{"id":"226","span":{"begin":13,"end":20},"obj":"Gene"}],"attributes":[{"id":"A216","pred":"pubann:denotes","subj":"216","obj":"Gene:3502"},{"id":"A217","pred":"pubann:denotes","subj":"217","obj":"Gene:3502"},{"id":"A218","pred":"pubann:denotes","subj":"218","obj":"Gene:2214"},{"id":"A224","pred":"pubann:denotes","subj":"224","obj":"Tax:9606"},{"id":"A226","pred":"pubann:denotes","subj":"226","obj":"Gene:2212"}],"text":"; mast cells\nFcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes\nFcγRIIc a Low IgG1, IgG3, IgG4 NK cells\nFcγRIIIa Low Ig"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T63","span":{"begin":13,"end":159},"obj":"Sentence"},{"id":"T64","span":{"begin":160,"end":202},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"; mast cells\nFcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes\nFcγRIIc a Low IgG1, IgG3, IgG4 NK cells\nFcγRIIIa Low Ig"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T78","span":{"begin":2,"end":6},"obj":"Protein"}],"attributes":[{"id":"A78","pred":"uniprot_id","subj":"T78","obj":"https://www.uniprot.org/uniprot/Q9NL57"},{"id":"A79","pred":"uniprot_id","subj":"T78","obj":"https://www.uniprot.org/uniprot/Q9NBD7"},{"id":"A80","pred":"uniprot_id","subj":"T78","obj":"https://www.uniprot.org/uniprot/A4V279"}],"text":"; mast cells\nFcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes\nFcγRIIc a Low IgG1, IgG3, IgG4 NK cells\nFcγRIIIa Low Ig"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T96","span":{"begin":2,"end":12},"obj":"Body_part"},{"id":"T97","span":{"begin":7,"end":12},"obj":"Body_part"},{"id":"T98","span":{"begin":108,"end":118},"obj":"Body_part"},{"id":"T99","span":{"begin":123,"end":132},"obj":"Body_part"},{"id":"T100","span":{"begin":146,"end":159},"obj":"Body_part"},{"id":"T101","span":{"begin":194,"end":202},"obj":"Body_part"},{"id":"T102","span":{"begin":197,"end":202},"obj":"Body_part"}],"attributes":[{"id":"A96","pred":"fma_id","subj":"T96","obj":"http://purl.org/sig/ont/fma/fma66784"},{"id":"A97","pred":"fma_id","subj":"T97","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A98","pred":"fma_id","subj":"T98","obj":"http://purl.org/sig/ont/fma/fma62852"},{"id":"A99","pred":"fma_id","subj":"T99","obj":"http://purl.org/sig/ont/fma/fma62851"},{"id":"A100","pred":"fma_id","subj":"T100","obj":"http://purl.org/sig/ont/fma/fma62869"},{"id":"A101","pred":"fma_id","subj":"T101","obj":"http://purl.org/sig/ont/fma/fma63147"},{"id":"A102","pred":"fma_id","subj":"T102","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"; mast cells\nFcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes\nFcγRIIc a Low IgG1, IgG3, IgG4 NK cells\nFcγRIIIa Low Ig"}

{"project":"LitCovid-sentences","denotations":[{"id":"T63","span":{"begin":13,"end":159},"obj":"Sentence"},{"id":"T64","span":{"begin":160,"end":202},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"; mast cells\nFcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes\nFcγRIIc a Low IgG1, IgG3, IgG4 NK cells\nFcγRIIIa Low Ig"}

{"project":"LitCovid-sample-Glycan","denotations":[{"id":"T1","span":{"begin":104,"end":107},"obj":"https://glytoucan.org/Structures/Glycans/G05518TD"}],"text":"; mast cells\nFcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes\nFcγRIIc a Low IgG1, IgG3, IgG4 NK cells\nFcγRIIIa Low Ig"}